|
|
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial
Vincent Ribrag
,
Serge Koscielny
,
Jacques Bosq
,
Thibaut Leguay
,
Olivier Casasnovas
et al.
Journal articles
inserm-01419476v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma
Steven Le Gouill
,
Catherine Thieblemont
,
Lucie Oberic
,
Anne Moreau
,
Krimo Bouabdallah
et al.
Journal articles
hal-02329536v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Accurate Classification of Germinal Center B-Cell-Like/Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Using a Simple and Rapid Reverse Transcriptase-Multiplex Ligation-Dependent Probe Amplification Assay: A CALYM Study.
Sylvain Mareschal
,
Philippe Ruminy
,
Cristina Bagacean
,
Vinciane Marchand
,
Marie Cornic
et al.
Journal articles
hal-01145953v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma
Bertrand Coiffier
,
Catherine Thieblemont
,
Sophie de Guibert
,
Jehan Dupuis
,
Vincent Ribrag
et al.
Journal articles
hal-01295660v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study
Hervé Tilly
,
Franck Morschhauser
,
Olivier Casasnovas
,
Thierry Jo Molina
,
Pierre Feugier
et al.
Journal articles
hal-02329073v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSA
Roch Houot
,
Carole Soussain
,
Hervé Tilly
,
Corinne Haioun
,
Catherine Thieblemont
et al.
Journal articles
hal-01295653v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases
Sydney Dubois
,
Pierre-Julien Viailly
,
Elodie Bohers
,
Philippe Bertrand
,
Philippe Ruminy
et al.
Journal articles
hal-01526582v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study.
Emilie Reboursiere
,
Fabien Le Bras
,
Charles Herbaux
,
Emmanuel Gyan
,
Aline Clavert
et al.
Journal articles
hal-01475957v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Recurrent Mutations of the Exportin 1 Gene (XPO1) in Primary Mediastinal B-Cell Lymphoma: A Lysa Study
Fabrice Jardin
,
Anaïs Pujals
,
Laura Pelletier
,
Elodie Bohers
,
Vincent Camus
et al.
Blood, 2015, 126 (23), pp.129
Journal articles
hal-01300803v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group
Christophe Bonnet
,
Jehan Dupuis
,
Hervé Tilly
,
Thierry Lamy
,
Christophe Fruchart
et al.
Journal articles
hal-03660656v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Abstract 4810: Exome sequencing of refractory diffuse large B-cell lymphomas highlights candidate genes for targeted resequencing
Sylvain Mareschal
,
Pierre-Julien Viailly
,
Philippe Bertrand
,
Elodie Bohers
,
Jean-Philippe Jais
et al.
Conference poster
hal-01300809v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of doxorubicin dose capping on the outcome of DLBCL patients with elevated body surface area
Caroline Gay
,
Richard Delarue
,
Noël Milpied
,
Lucie Oberic
,
Bertrand Coiffier
et al.
Journal articles
hal-01558813v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma a phase II LYSA study
Roch Houot
,
Guillaume Cartron
,
Fontanet Bijou
,
Sophie de Guibert
,
Gilles A Salles
et al.
Journal articles
hal-01903056v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma
Franck Morschhauser
,
Gilles Salles
,
Steven Le Gouill
,
Hervé Tilly
,
Catherine Thieblemont
et al.
Journal articles
hal-01928199v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Integrative Analysis of Diffuse Large B Cell Lymphoma Mutational Landscape: A Lysa Study
Sydney Dubois
,
Bruno Tesson
,
Pierre-Julien Viailly
,
Thierry Molina
,
Christiane Copie-Bergman
et al.
Blood, 2015, 126 (23), pp.1472
Journal articles
hal-01300813v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.
Céline Pangault
,
Patricia Amé-Thomas
,
Philippe Ruminy
,
Delphine Rossille
,
Gersende Caron
et al.
Journal articles
inserm-00570274v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and Non-L265P Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases
Sydney Dubois
,
Pierre-Julien Viailly
,
Elodie Bohers
,
Philippe Bertrand
,
Philippe Ruminy
et al.
Conference poster
hal-02482497v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants.
Judith Trotman
,
Marion Fournier
,
Thierry Lamy
,
John Francis Seymour
,
Anne Sonet
et al.
Journal articles
hal-00741692v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma
Roch Houot
,
Viola Poeschel
,
Bettina Altmann
,
Stephanie Angel
,
Lorenz Thurner
et al.
Journal articles
hal-03575963v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Abstract 4947: HACE1 is a putative tumor suppressor gene in B-cell lymphomagenesis down-regulated by both deletion and epigenetic mechanisms
Abdelilah Bouzelfen
,
Marion Alcantara
,
Hafid Kora
,
Philippe Bertrand
,
Sylvain Mareschal
et al.
Conference poster
hal-01300808v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study
Sydney Dubois
,
Pierre-Julien Viailly
,
Sylvain Mareschal
,
Elodie Bohers
,
Philippe Bertrand
et al.
Journal articles
hal-01343064v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Hervé Ghesquières
,
Susan L. Slager
,
Fabrice Jardin
,
Amelie S. Veron
,
Yan W. Asmann
et al.
Journal articles
hal-01217986v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma
Sylvain Mareschal
,
Sydney Dubois
,
Pierre-Julien Viailly
,
Philippe Bertrand
,
Elodie Bohers
et al.
Journal articles
istex
hal-01237083v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group
Steven Le Gouill
,
Asma Beldi-Ferchiou
,
Marion Alcantara
,
Victoria Cacheux
,
Violaine Safar
et al.
Journal articles
hal-03012903v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Somatic mutations of cell-free circulating DNA detected by Next Generation Sequencing reflect the genetic changes in both Germinal Center B-Cell like and Activated B-Cell like Diffuse Large B-Cell Lymphoma tumors at the time of diagnosis
Elodie Bohers
,
Pierre Julien Viailly
,
Sydney Dubois
,
Philippe Bertrand
,
Catherine Maingonnat
et al.
Journal articles
hal-01132460v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study
Franck Morschhauser
,
Steven Le Gouill
,
Pierre Feugier
,
Sarah Bailly
,
Emmanuelle Nicolas-Virelizier
et al.
Journal articles
hal-02586078v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|